| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net income | 484,100 | 460,600 | 686,500 | 556,100 |
| Depreciation, amortization and impairment of property, equipment and software | 68,800 | 202,100 | 70,800 | 69,300 |
| Amortization and impairment of acquisition-related assets and retention arrangements | 33,900 | 33,900 | 49,400 | 67,400 |
| Fair value remeasurement of contingent consideration liability | NaN | 0 | 0 | NaN |
| Stock-based compensation expense | 49,100 | 82,700 | 37,300 | 46,600 |
| Net (gains) losses recognized on investments | -13,600 | 104,900 | 173,700 | 165,500 |
| Net redemptions in investment products used to economically hedge deferred compensation liabilities | 39,200 | -102,000 | 38,700 | 25,400 |
| Net change in securities held by consolidated investment products | 168,900 | 181,300 | 411,900 | 409,500 |
| Other changes in assets and liabilities | -304,500 | 409,800 | -312,200 | -177,100 |
| Net cash provided by operating activities | 824,300 | -18,700 | 609,300 | 529,900 |
| Purchases of sponsored investment products | 10,300 | -22,000 | 20,900 | 40,400 |
| Dispositions of sponsored investment products | 82,600 | 296,100 | 249,500 | 103,700 |
| Net cash of investment products upon deconsolidation | -500 | -27,300 | -34,700 | -4,800 |
| Additions to property, equipment and software | 62,000 | 66,700 | 63,300 | 62,200 |
| Other investing activity | -49,800 | -25,100 | 92,700 | 5,300 |
| Net cash provided by (used in) investing activities | 59,600 | 249,200 | 37,900 | -9,000 |
| Repurchases of common stock | 333,500 | 139,100 | 153,500 | 113,100 |
| Common share issuances under stock-based compensation plans | 100 | -52,500 | 13,700 | 1,300 |
| Dividends paid to common stockholders and equity-unit holders | 289,100 | 284,500 | 283,400 | 285,600 |
| Net contributions (distributions) to non-controlling interests in consolidated entities | -10,900 | -28,800 | -100 | -5,600 |
| Net subscriptions from redeemable non-controlling interest holders | 131,400 | 13,100 | 325,000 | 127,100 |
| Net cash used in financing activities | -502,000 | -491,800 | -98,300 | -275,900 |
| Effect of exchange rate changes on cash and cash equivalents of consolidated investment products | -2,800 | -5,300 | 4,500 | -2,000 |
| Net change in cash and cash equivalents during period | 379,100 | -266,600 | 553,400 | 243,000 |
| Cash and cash equivalents at beginning of year | 39,100 | NaN | NaN | NaN |
| Cash and cash equivalents at end of period | 66,600 | NaN | NaN | NaN |
PRICE T ROWE GROUP INC (TROW)
PRICE T ROWE GROUP INC (TROW)